Hypertension and Dementia: A comprehensive review from the HOPE Asia Network
- PMID: 31131972
- PMCID: PMC8030451
- DOI: 10.1111/jch.13558
Hypertension and Dementia: A comprehensive review from the HOPE Asia Network
Abstract
Approximately 365 million people in Asia were classified as elderly in 2017. This number is rising and expected to reach approximately 520 million by 2030. The risk of hypertension and cognitive impairment/dementia increases with age. Recent data also show that the prevalence of hypertension and age-related dementia are rising in Asian countries. Moreover, not many people in Asian countries are aware of the relationship between hypertension and cognitive impairment/dementia. Furthermore, hypertension control is poorer in Asia than in developed countries. Hypertension is known to be a major risk factor for damage to target organs, including the brain. Decreased cognitive function can indicate the presence of target organ damage in the brain. Twenty-four-hour blood pressure profiles and blood pressure variability have been associated with cognitive impairment and/or silent cerebral diseases, such as silent cerebral infarction or white matter lesions, which are predisposing conditions for cognitive impairment and dementia. Hypertension that occurs in midlife also affects the incidence of cognitive impairments in later life. Managing and controlling blood pressure could preserve cognitive functions, such as by reducing the risk of vascular dementia and by reducing the global burden of stroke, which also affects cognitive function.
Keywords: Asia; cognitive dysfunction; dementia; hypertension.
©2019 Wiley Periodicals, Inc.
Conflict of interest statement
K Kario received research grants from Teijin Pharma, Omron Healthcare, Fukuda Denshi, Bayer Yakuhin, A&D, Daiichi Sankyo, Mochida Pharmaceutical, EA Pharma, Boehringer Ingelheim Japan, Tanabe Mitsubishi Pharma, Shionogi & Co., MSD KK, Sanwa Kagaku Kenkyusho, Bristol‐Myers Squibb KK, Pfizer Japan, and Otsuka Holdings, and honoraria from Takeda Pharmaceutical, Daiichi Sankyo, Omron Healthcare, and Terumo Corporation. S Park has received research grants and honoraria from Pfizer. S Siddique has received honoraria from Bayer, GlaxoSmithKline, Pfizer, ICI, and Servier; and travel, accommodation and conference registration support from Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, ICI, and Pfizer. YC Chia has received honoraria and sponsorship to attend conferences and CME seminars from Abbott, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Novartis, Orient Europharma, Pfizer, and Sanofi; and a research grant from Pfizer. J Shin has received honoraria and sponsorship to attend seminars from Daiichi Sankyo, Takeda, Menarini, MSD, Bristol‐Myers Squibb, and Sanofi. CH Chen has received honoraria as a member of a speaker's bureau for Pfizer. R Divinagracia has received honoraria as a member of speaker's bureaus for Bayer, Novartis, and Pfizer. J Sison has received honoraria from Pfizer, AstraZeneca, Boehringer Ingelheim, and Novartis. GP Sogunuru has received a research grant related to hypertension monitoring and treatment from Pfizer. JC Tay has received advisory board and consultant honoraria from Pfizer. JG Wang has received research grants from Bayer, Pfizer, and Phillips; and lecture and consulting fees from Bayer, Daiichi Sankyo, Merck Sharp & Dohme, Pfizer, Sanofi, and Servier. L Wong has received honoraria from Bristol‐Myers Squibb and Pfizer. Y Zhang has received research grants from Bayer, Novartis, and Shuanghe; and lecture fees from Bayer, Daiichi Sankyo, Novartis, Pfizer, Sanofi, Servier, and Takeda. All other authors report no potential conflicts of interest in relation to this article.
Figures
Similar articles
-
Treating Hypertension to Prevent Cognitive Decline and Dementia: Re-Opening the Debate.Adv Exp Med Biol. 2017;956:447-473. doi: 10.1007/5584_2016_98. Adv Exp Med Biol. 2017. PMID: 27757933 Review.
-
High burden of cerebral white matter lesion in 9 Asian cities.Sci Rep. 2021 Jun 2;11(1):11587. doi: 10.1038/s41598-021-90746-x. Sci Rep. 2021. PMID: 34078946 Free PMC article.
-
Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?High Blood Press Cardiovasc Prev. 2016 Jun;23(2):97-104. doi: 10.1007/s40292-016-0144-5. Epub 2016 Apr 13. High Blood Press Cardiovasc Prev. 2016. PMID: 27075454 Review.
-
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.Pharmacotherapy. 2008 Mar;28(3):366-75. doi: 10.1592/phco.28.3.366. Pharmacotherapy. 2008. PMID: 18294116 Review.
-
Hypertension and Mild Cognitive Impairment: State-of-the-Art Review.Am J Hypertens. 2024 May 15;37(6):385-393. doi: 10.1093/ajh/hpae007. Am J Hypertens. 2024. PMID: 38214550 Review.
Cited by
-
Sex Difference in the Associations among Obesity-Related Indices with Incident Hypertension in a Large Taiwanese Population Follow-Up Study.J Pers Med. 2022 Jun 15;12(6):972. doi: 10.3390/jpm12060972. J Pers Med. 2022. PMID: 35743756 Free PMC article.
-
An Investigation of Water Diffusivity Changes along the Perivascular Space in Elderly Subjects with Hypertension.AJNR Am J Neuroradiol. 2022 Jan;43(1):48-55. doi: 10.3174/ajnr.A7334. Epub 2021 Nov 18. AJNR Am J Neuroradiol. 2022. PMID: 34794943 Free PMC article.
-
Hypertension and stroke in Asia: A comprehensive review from HOPE Asia.J Clin Hypertens (Greenwich). 2021 Mar;23(3):513-521. doi: 10.1111/jch.14099. Epub 2020 Nov 15. J Clin Hypertens (Greenwich). 2021. PMID: 33190399 Free PMC article. Review.
-
A Meta-Analysis of the Relationship between Stroke and Alzheimer's Disease: Therapeutic and Prognostic Implications.Kidney Blood Press Res. 2025;50(1):481-495. doi: 10.1159/000546395. Epub 2025 Jun 5. Kidney Blood Press Res. 2025. PMID: 40472826 Free PMC article.
-
Insomnia: Risk Factor for Neurodegenerative Diseases.Cureus. 2019 Oct 26;11(10):e6004. doi: 10.7759/cureus.6004. Cureus. 2019. PMID: 31807391 Free PMC article. Review.
References
-
- Gulland A. Global life expectancy increases by five years. BMJ. 2016;19(353):i2883. - PubMed
-
- WHO . Life expectancy [Internet]. WHO. Available from: http://www.who.int/gho/mortality_burden_disease/life_tables/situation_tr.... Accessed November 8, 2018.
-
- Goh VH. Aging in Asia: a cultural, socio‐economical and historical perspective. Aging Male. 2005;8(2):90‐96. - PubMed
-
- Post TJ. How Asia’s population is aging, 2015–2030 scenario [Internet]. The Jakarta Post. Available from: http://www.thejakartapost.com/news/2018/02/14/how-asias-population-is-ag.... Accessed November 8, 2018.
-
- Allaudeen A. Asia is expected to be home to more than half of the elderly population worldwide by 2030 [Internet]. Business Insider. Available from: https://www.businessinsider.com/asia-will-be-home-to-more-than-half-of-t.... Accessed November 8, 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical